Vanguard Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.9M Buy
4,072,661
+121,492
+3% +$1.51M ﹤0.01% 1841
2026
Q2
$42.8M Buy
3,951,169
+264,162
+7% +$2.4M ﹤0.01% 2031
2026
Q1
$46.7M Buy
+3,687,007
New +$41.9M ﹤0.01% 1888

Other funds holding ORIC

Vanguard Capital Management's ORIC Position: Q3 2026 in Review

Vanguard Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 3.1% in Q3 2026, buying an estimated $1.51M and bringing the position to 4,072,661 shares worth $54.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

Vanguard Capital Management first reported a position in ORIC in Q1 2026 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Vanguard Capital Management held 4,072,661 shares of Oric Pharmaceuticals worth $54.9M as of Q3 2026.
  • Vanguard Capital Management bought 121,492 Oric Pharmaceuticals shares in Q3 2026, an estimated $1.51M.
  • Oric Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1841 holding.
  • Vanguard Capital Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.